Listed on GrantGunner. Last checked 23 Jun 2026.
About this grant
Beijing Institute of Stem Cell and Regenerative Medicine has launched the 'Clinical Translation Acceleration Program,' calling for applications for 2026 clinical translation research projects from universities, research institutes, and hospitals. The projects cover areas including stem cell and regenerative medicine, organoid technology, new drug development, and translational applications. The program adopts a phased rolling funding mechanism, with a maximum funding intensity of up to 10 million yuan per project and an implementation period of 1 to 4 years.
Who can apply
China’s institutions of higher education, research institutes, and hospitals with independent legal personality.
More grants from Beijing Institute of Stem Cell and Regenerative Medicine